Relay Therapeutics (RLAY) Other Gross PP&E Adjustments (2020 - 2025)
Relay Therapeutics (RLAY) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$32.4 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 4.3% to -$32.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$32.4 million, a 4.3% increase, with the full-year FY2025 number at -$32.4 million, up 4.3% from a year prior.
- Other Gross PP&E Adjustments was -$32.4 million for Q4 2025 at Relay Therapeutics, up from -$41.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$8.2 million in Q4 2021 to a low of -$65.2 million in Q3 2022.
- A 5-year average of -$42.0 million and a median of -$43.6 million in 2025 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: tumbled 485.16% in 2022, then rose 22.06% in 2025.
- Relay Therapeutics' Other Gross PP&E Adjustments stood at -$8.2 million in 2021, then crashed by 485.16% to -$48.2 million in 2022, then increased by 11.0% to -$42.9 million in 2023, then grew by 21.2% to -$33.8 million in 2024, then grew by 4.3% to -$32.4 million in 2025.
- Per Business Quant, the three most recent readings for RLAY's Other Gross PP&E Adjustments are -$32.4 million (Q4 2025), -$41.6 million (Q3 2025), and -$43.6 million (Q2 2025).